This new research, published in the Genes & Diseases journal by a team from Hunan University, Texas A&M University Colleges ...
Background Although health problems may persist beyond 4 weeks after SARS-CoV-2 infection, evidence on long-term ophthalmic ...
Former White House Covid-19 Response Coordinator and Sr. Fellow at Harvard’s Kennedy School Dr. Ashish Jha explains how hantavirus spreads and how lessons learned during the pandemic could apply now.
Hosted on MSN
Another coronavirus threat on the way? New international study finds SARS-CoV-2 relatives that can infect humans
It’s been over six years since COVID-19 upended everything, and researchers are raising a new warning: relatives of the SARS-CoV-2 virus are still out there, circulating in animals, potentially ...
Patients with systemic autoimmune rheumatic disease demonstrate an increased persistence of SARS-CoV-2 antigen positivity up ...
Early treatment with ensitrelvir in SARS-CoV-2-negative individuals exposed to COVID-19 may help prevent infection.
A Tempo fact check debunks social media claims that the Hantavirus is a laboratory-engineered conspiracy or an agenda for vaccine commercialization.
Vaccine makers Moderna and Sanofi discussed data on mice research suggesting that vaccines targeting XFG trigger higher antibody concentrations against circulating SARS-CoV-2 strains than Pfizer’s and ...
Live Science on MSN
A pill can stop people from developing COVID after being exposed to the virus, trial finds
A pill called ensitrelvir is the first drug shown to effectively reduce infection after exposure to SARS-CoV-2.
Widespread brain inflammation diminishes over time in Long COVID, shifting the clinical focus to emotional regulation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results